ESC 365 - GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

ESC Premium Access

GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy

Session: Young Investigator Awards Session in Thrombosis

Topic: Pharmacotherapy

Speaker: Mr F. Alenazy (Birmingham, GB)

Event: ESC Congress 2021 - The Digital Experience

Congress Presentation

About the speaker

Mr Fawaz Alenazy

Birmingham (United Kingdom of Great Britain & Northern Ireland)

0 follower

3 more presentations in this session

JCAD enhances arterial thrombosis by regulating endothelial plasminogen activator inhibitor-1 and tissue factor expression

Speaker: Doctor L. Liberale (Genova, IT)

In vivo coronary artery thrombus imaging with 18F-GP1 PET-CT

Speaker: Doctor E. Tzolos (Edinburgh, GB)

Sustained endothelial, coagulation and inflammatory cytokine activation without macrovascular dysfunction at 3 months after COVID-19: a reflection on SARS-CoV-2 induced thrombo-inflammation

Speaker: Ms L. Willems (Nijmegen, NL)

Access the full session

Young Investigator Awards Session in Thrombosis

Speakers: Mr F. Alenazy, Doctor L. Liberale, Doctor E. Tzolos, Ms L. Willems

About the event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Congress

ESC 365 is supported by